Topics

Gut-microbiota Targeted Nutritional Intervention for Gut Barrier Integrity at High Altitude

2019-10-07 08:56:51 | BioPortfolio

Summary

The aim of this randomized, crossover clinical trial is to determine the efficacy of a gut microbiota-targeted nutritional intervention containing a blend of fermentable fibers and polyphenols (FP) for mitigating increases in GI permeability, and decrements in immune function and neuropsychologic performance following rapid ascent to simulated high altitude. Fifteen healthy young adults will participate in each of three study phases that include a 14-day supplementation period in which participants will consume 1 of 2 supplement bars: placebo (PL, will be consumed during 2 phases) and FP supplementation (will be consumed during one phase only). During the final 2-d of each phase, participants will live in a hypobaric chamber under sea level or high altitude conditions.

Description

The collection of microbes inhabiting the human gastrointestinal (GI) tract, known as the gut microbiota, is increasingly recognized as a mediator of GI, immunologic, and neuropsychologic responses to various environmental and physiologic stressors. The hypobaric hypoxia characteristic of high altitude environments is a stressor that has recently been associated with increased GI permeability, and which has been shown to cause decrements in immune, neuropsychological and physical function. To what extent modulation of the human gut microbiota can mitigate these responses during high altitude exposure is undetermined. The aim of this randomized, crossover clinical trial is to determine the efficacy of a gut microbiota-targeted nutritional intervention containing a blend of fermentable fibers and polyphenols (FP) for mitigating increases in GI permeability, and decrements in immune function and neuropsychologic performance following rapid ascent to simulated high altitude. Fifteen healthy young adults will participate in each of three study phases in random order. Each phase will include a 14-day supplementation period in which participants will consume 1 of 2 supplement bars: placebo (PL, will be consumed during 2 phases) and FP supplementation (will be consumed during one phase only). During the final 2-d of each phase, participants will live in a hypobaric chamber. During one phase the chamber environment will mimic low-altitude conditions (SHAM). During two phases the chamber environment will mimic the barometric pressure at Pike's Peak CO (460 mmHg; HA).

Study Design

Conditions

Gastrointestinal Injury

Intervention

FP, Placebo, High altitude, Sea level

Location

USARIEM
Natick
Massachusetts
United States
01760

Status

Recruiting

Source

United States Army Research Institute of Environmental Medicine

Results (where available)

View Results

Links

Published on BioPortfolio: 2019-10-07T08:56:51-0400

Clinical Trials [2644 Associated Clinical Trials listed on BioPortfolio]

Acute Exposure to High Altitude on Symptoms

Randomized crossover Trial in patients with Pulmonary Hypertension (PAH, CTEPH) to assess the acute response to High Altitude (2500m above sea level) in altitude related symptoms

Acute Exposure of High Altitude on Cardiac Output

Randomized crossover trial in patients with Pulmonary Hypertension (PAH, CTEPH) to assess the acute response High Altitude (Säntis; 2500m above sea level) on non-invasive cardiac output a...

Acute Exposure to High Altitude on Exercise Capacity

Randomized crossover Trial in patients with Pulmonary Hypertension (PAH, CTEPH) to assess the acute response to High Altitude (2500m above sea level) in constant loaded exercise capacity.

Ghrelin, Growth Hormone and Growth Factors at High Altitude

Regulation of ghrelin, growth hormone and growth factors at high altitude and their change during ascent to high altitude has not been studied in depth yet. The study includes 33 volunteer...

Acute Exposure to High Altitude on Heart Rate and Ventilation During Exercise

Randomized crossover trial in patients with Pulmonary Hypertension (PAH, CTEPH) to assess the acute response to High Altitude (Säntis; 2500m above sea level) on heart rate and Ventilation ...

PubMed Articles [25698 Associated PubMed Articles listed on BioPortfolio]

Acetazolamide does not alter endurance exercise performance at 3500 m altitude.

Acetazolamide (AZ) is a medication commonly used to prevent acute mountain sickness (AMS) during rapid ascent to high altitude. However, it is unclear whether AZ use impairs exercise performance; prev...

Evaluation of Acute Mountain Sickness by Unsedated Transnasal Esophagogastroduodenoscopy at High Altitude.

It is not clear how rapid ascent to high altitude causes the gastrointestinal symptoms of acute mountain sickness (AMS). We assessed the incidence of endoscopic lesions in the upper gastrointestinal t...

Small non-coding RNA transcriptome of four high-altitude vertebrates and their low-altitude relatives.

Animals that lived at high altitudes have evolved distinctive physiological traits that allow them to tolerate extreme high-altitude environment, including higher hemoglobin concentration, increased o...

Natural Climbers: Insights from Avian Physiology at High Altitude.

High altitudes are physiologically challenging: the hypobaric hypoxia, cold, and increased ultraviolet radiation mean humans ascending to high altitude faster than they acclimatize risk life-threateni...

EFFECT OF HIGH ALTITUDE ON HUMAN PLACENTAL AMINO ACID TRANSPORT.

Women residing at high altitude deliver infants of lower birth weight than at sea-level. Birth weight correlates with placental System A-mediated amino acid transport capacity and severe environmental...

Medical and Biotech [MESH] Definitions

A vertical distance measured from a known level on the surface of a planet or other celestial body.

A morbid condition of ANOXIA caused by the reduced available oxygen at high altitudes.

Cell surface proteins that bind gastrointestinal hormones with high affinity and trigger intracellular changes influencing the behavior of cells. Most gastrointestinal hormones also act as neurotransmitters so these receptors are also present in the central and peripheral nervous systems.

A natural high-viscosity mucopolysaccharide with alternating beta (1-3) glucuronide and beta (1-4) glucosaminidic bonds. It is found in the UMBILICAL CORD, in VITREOUS BODY and in SYNOVIAL FLUID. A high urinary level is found in PROGERIA.

Misunderstanding among individuals, frequently research subjects, of scientific methods such as randomization and placebo controls.

More From BioPortfolio on "Gut-microbiota Targeted Nutritional Intervention for Gut Barrier Integrity at High Altitude"

Quick Search

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...


Searches Linking to this Trial